600 related articles for article (PubMed ID: 23955151)
21. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.
Ebihara T; Endo R; Kikuta H; Ishiguro N; Ishiko H; Kobayashi K
J Med Virol; 2004 Feb; 72(2):304-6. PubMed ID: 14695674
[TBL] [Abstract][Full Text] [Related]
23. Dendritic cells in human Pneumovirus and Metapneumovirus infections.
Guerrero-Plata A
Viruses; 2013 Jun; 5(6):1553-70. PubMed ID: 23787776
[TBL] [Abstract][Full Text] [Related]
24. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.
Mousa JJ; Kose N; Matta P; Gilchuk P; Crowe JE
Nat Microbiol; 2017 Jan; 2():16271. PubMed ID: 28134924
[TBL] [Abstract][Full Text] [Related]
25. Immunization strategies for the prevention of pneumovirus infections.
Bennett N; Ellis J; Bonville C; Rosenberg H; Domachowske J
Expert Rev Vaccines; 2007 Apr; 6(2):169-82. PubMed ID: 17408367
[TBL] [Abstract][Full Text] [Related]
26. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.
Ulbrandt ND; Ji H; Patel NK; Riggs JM; Brewah YA; Ready S; Donacki NE; Folliot K; Barnes AS; Senthil K; Wilson S; Chen M; Clarke L; MacPhail M; Li J; Woods RM; Coelingh K; Reed JL; McCarthy MP; Pfarr DS; Osterhaus AD; Fouchier RA; Kiener PA; Suzich JA
J Virol; 2006 Aug; 80(16):7799-806. PubMed ID: 16873237
[TBL] [Abstract][Full Text] [Related]
28. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein.
Huang J; Miller RJ; Mousa JJ
Front Immunol; 2022; 13():941865. PubMed ID: 36003370
[TBL] [Abstract][Full Text] [Related]
29. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.
Ulbrandt ND; Ji H; Patel NK; Barnes AS; Wilson S; Kiener PA; Suzich J; McCarthy MP
J Gen Virol; 2008 Dec; 89(Pt 12):3113-3118. PubMed ID: 19008400
[TBL] [Abstract][Full Text] [Related]
30. A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.
Zhang Y; Brooks WA; Goswami D; Rahman M; Luby SP; Erdman DD
J Virol Methods; 2014 Sep; 206():55-62. PubMed ID: 24859050
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
Taylor G; Thom M; Capone S; Pierantoni A; Guzman E; Herbert R; Scarselli E; Napolitano F; Giuliani A; Folgori A; Colloca S; Cortese R; Nicosia A; Vitelli A
Sci Transl Med; 2015 Aug; 7(300):300ra127. PubMed ID: 26268314
[TBL] [Abstract][Full Text] [Related]
32. VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
Trinité B; Durr E; Pons-Grífols A; O'Donnell G; Aguilar-Gurrieri C; Rodriguez S; Urrea V; Tarrés F; Mane J; Ortiz R; Rovirosa C; Carrillo J; Clotet B; Zhang L; Blanco J
Vaccine; 2024 May; 42(15):3474-3485. PubMed ID: 38641492
[TBL] [Abstract][Full Text] [Related]
33. Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus.
Ou L; Chen SJ; Teng IT; Yang L; Zhang B; Zhou T; Biju A; Cheng C; Kong WP; Morano NC; Stancofski ED; Todd JP; Tsybovsky Y; Wang S; Zheng CY; Mascola JR; Shapiro L; Woodward RA; Buchholz UJ; Kwong PD
PLoS Pathog; 2023 Sep; 19(9):e1011584. PubMed ID: 37738240
[TBL] [Abstract][Full Text] [Related]
34. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
Tang RS; Mahmood K; Macphail M; Guzzetta JM; Haller AA; Liu H; Kaur J; Lawlor HA; Stillman EA; Schickli JH; Fouchier RA; Osterhaus AD; Spaete RR
Vaccine; 2005 Feb; 23(14):1657-67. PubMed ID: 15705469
[TBL] [Abstract][Full Text] [Related]
35. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
[TBL] [Abstract][Full Text] [Related]
36. Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China.
Lu G; Gonzalez R; Guo L; Wu C; Wu J; Vernet G; Paranhos-Baccalà G; Wang J; Hung T
Virol J; 2011 Feb; 8():62. PubMed ID: 21310026
[TBL] [Abstract][Full Text] [Related]
37. Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV.
Steff AM; Monroe J; Friedrich K; Chandramouli S; Nguyen TL; Tian S; Vandepaer S; Toussaint JF; Carfi A
Nat Commun; 2017 Oct; 8(1):1085. PubMed ID: 29057917
[TBL] [Abstract][Full Text] [Related]
38. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.
Williams JV; Chen Z; Cseke G; Wright DW; Keefer CJ; Tollefson SJ; Hessell A; Podsiad A; Shepherd BE; Sanna PP; Burton DR; Crowe JE; Williamson RA
J Virol; 2007 Aug; 81(15):8315-24. PubMed ID: 17522220
[TBL] [Abstract][Full Text] [Related]
39. Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode.
Wen X; Suryadevara N; Kose N; Liu J; Zhan X; Handal LS; Williamson LE; Trivette A; Carnahan RH; Jardetzky TS; Crowe JE
Cell Host Microbe; 2023 Aug; 31(8):1288-1300.e6. PubMed ID: 37516111
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
